Triple-negative breast cancer: a new clinical study opens new and promising therapeutic prospects. | McGill University Health Centre

1 year ago 28

Montreal, November 27, 2023 — The Research Institute of the McGill University Health Centre (RI-MUHC) will host a new Phase 3 randomized clinical trial called TROPION-Breast04, as announced today by the McPeak-Sirois Group, a provincial consortium of cancer centres across Q

1. Homepage
2. Breast Cancer
3. Triple-negative breast cancer: a new clinical study opens new and promising therapeutic prospects. | McGill University Health Centre